These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18259989)

  • 1. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.
    Park SJ; Lee YC
    J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma.
    Kim SR; Lee KS; Park HS; Park SJ; Min KH; Jin SM; Lee YC
    Mol Pharmacol; 2005 Dec; 68(6):1568-75. PubMed ID: 16150927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
    Belvisi MG; Hele DJ; Birrell MA
    Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
    Park SJ; Lee KS; Kim SR; Min KH; Choe YH; Moon H; Chae HJ; Yoo WH; Lee YC
    J Immunol; 2009 Sep; 183(5):3259-67. PubMed ID: 19641141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components.
    Martin H
    Mutat Res; 2009 Oct; 669(1-2):1-7. PubMed ID: 19563816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells.
    Ogawa D; Nomiyama T; Nakamachi T; Heywood EB; Stone JF; Berger JP; Law RE; Bruemmer D
    Circ Res; 2006 Apr; 98(7):e50-9. PubMed ID: 16556873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice.
    Akahori T; Sho M; Hamada K; Suzaki Y; Kuzumoto Y; Nomi T; Nakamura S; Enomoto K; Kanehiro H; Nakajima Y
    J Hepatol; 2007 Dec; 47(6):784-92. PubMed ID: 17936399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma and its ligands in controlling interleukin-1beta target gene expression: a confusing story.
    François M; Richette P; Corvol MT
    Drug News Perspect; 2005 May; 18(4):257-61. PubMed ID: 16034482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARgamma as a new therapeutic target in inflammatory bowel diseases.
    Dubuquoy L; Rousseaux C; Thuru X; Peyrin-Biroulet L; Romano O; Chavatte P; Chamaillard M; Desreumaux P
    Gut; 2006 Sep; 55(9):1341-9. PubMed ID: 16905700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies.
    Gurnell M
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):501-23. PubMed ID: 16311214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular effects of PPARgamma activators - from bench to bedside.
    Marx N; Walcher D
    Prog Lipid Res; 2007 Nov; 46(6):283-96. PubMed ID: 17637478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PPARgamma in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential.
    Yang J; Zhang D; Li J; Zhang X; Fan F; Guan Y
    Clin Sci (Lond); 2009 Jan; 116(1):17-26. PubMed ID: 19037881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium bovis bacillus Calmette-Guérin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis.
    Almeida PE; Silva AR; Maya-Monteiro CM; Töröcsik D; D'Avila H; Dezsö B; Magalhães KG; Castro-Faria-Neto HC; Nagy L; Bozza PT
    J Immunol; 2009 Jul; 183(2):1337-45. PubMed ID: 19561094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and their therapeutic utility.
    Henke BR
    Prog Med Chem; 2004; 42():1-53. PubMed ID: 15003718
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
    Becker J; Delayre-Orthez C; Frossard N; Pons F
    Fundam Clin Pharmacol; 2006 Oct; 20(5):429-47. PubMed ID: 16968414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARgamma and atherosclerosis.
    Staels B
    Curr Med Res Opin; 2005; 21 Suppl 1():S13-20. PubMed ID: 15811195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effect of peroxisome proliferator activated receptor gamma on human dental pulp cells.
    Yu MK; Lee JC; Kim JH; Lee YH; Jeon JG; Jhee EC; Yi HK
    J Endod; 2009 Apr; 35(4):524-8. PubMed ID: 19345798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the labeling of halogen-substituted peroxisome proliferator-activated receptor gamma ligands: potential positron emission tomography and single photon emission computed tomography imaging agents.
    Lee BC; Lee KC; Lee H; Mach RH; Katzenellenbogen JA
    Bioconjug Chem; 2007; 18(2):514-23. PubMed ID: 17315977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolism.
    Fogo AB
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):282-5. PubMed ID: 18408479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The many faces of PPARgamma.
    Lehrke M; Lazar MA
    Cell; 2005 Dec; 123(6):993-9. PubMed ID: 16360030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.